Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-13.97	114.88	133.54
Graham Fair Price	-37.17	32.42	51.60
PEG	-76.65	-1.76	7.55
Price/Book	-2.29	16.41	16.79
Price/Cash Flow	24.67	223.08	178.94
Prices/Earnings	118.75	102.28	46.76
Price/Sales	-10.91	48.95	54.94
Price/FCF	24.67	223.08	178.94
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.34	0.89	0.87
Operating Margin	-49.31	0.18	0.35
ROA	-56.70	0.02	0.05
ROE	0.09	0.04	-55.33
ROIC	0.07	0.03	-57.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-62.35
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.03	-0.48	1669.43
EPS QOQ	0.06	-0.58	836.76
FCF QOQ	-0.13	-0.27	-104.66
Revenue QOQ	0.03	0.03	-17.84
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	39.65	35.73	-9.90
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.20	0.21	5.54
Quick Ratio	1.22	0.93	-23.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	36.30	34.13	-5.99
Cash	17.24	15.06	-12.65
Capex	-0.10	-0.08	20.93
Free Cash Flow	3.41	2.51	-26.32
Revenue	11.09	11.44	3.11
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.34	1.05	-21.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.49	-0.99	33.54
Naive Interpretation	Member

06 - Financial Health · Bad

Rating